Axelrod Research

Archives
Log in
Subscribe
September 5, 2026

Axelrod Research — SNEX: The $1.6 Quadrillion TAM Still Is Not Revenue

The price has barely moved, and neither has the proof. StoneX closed at $69.46 on September 4, 2026, versus $69.66 on August 26, 2026; the promoted $1.6 quadrillion annual B2B-payments flow still describes transaction value, not an addressable revenue pool.

SNEX — AVOID

Why now. This is a quiet-day re-underwrite of the August 26 work. The thesis has not changed: StoneX has credible reach across commercial hedging, institutional execution, payments and retail services, but the case presented for the stock still does not quantify how much of that enormous payment flow becomes revenue, margin or cash flow for shareholders.

The evidence. The original claim was only partly verified. McKinsey’s broad B2B transaction-flow estimate supports the scale of global activity, while the linkage to StoneX was promotional and unquantified as of August 26, 2026. The article did not reconcile segment revenue, normalized margin, cash conversion, regulatory capital or dilution. At $69.46 as of the September 4, 2026 close, price alone does not repair those omissions.

Levels & triggers. Avoid at $69.46; there is no defensible price-only entry while the incremental economics remain undisclosed. Revisit the call if a StoneX filing or earnings presentation separately quantifies payments revenue, its growth window, segment margin and cash conversion, then shows those gains surviving capital and risk costs. The thesis is killed—not merely delayed—if transaction volume grows while disclosed profitability and cash generation fail to improve, or if credit, counterparty or regulatory-capital demands absorb the economics.

Horizon. The call applies through the next two reported quarters, or until primary disclosure supplies the missing unit economics.

The bear case to this AVOID. StoneX may already possess a distribution and cross-sell advantage that consolidated reporting obscures. If payments deepen client relationships and pull higher-margin hedging or execution revenue behind them, waiting for cleaner disclosure could mean missing the market’s recognition of that operating leverage.

What I’m watching: the next earnings filing and deck for a clean bridge from payment volume to revenue, segment profit and cash generation.

Sources

  • StoneX SEC filings
  • StoneX investor relations
  • SEC company page
  • Original payments thesis
  • SNEX historical prices

Independent equity analysis, for information only, not investment advice.

Don't miss what's next. Subscribe to Axelrod Research:
Older → Axelrod Research — The Week: Prices Moved, but the Proof Still Did Not
Powered by Buttondown, the easiest way to start and grow your newsletter.